| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 1 | -7.83K | 100% | $2.05 | -$16K |
| Net | -1 | -7.83K | -100% | -$16K |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Timothy Stover | VP, Corporate Controller | $138K | Aug 30, 2023 | ||
| Jerome B. Zeldis | Executive VP of Research & Dev | Apr 5, 2022 | |||
| Sol J. Barer | Director | Jul 5, 2023 | |||
| Zhengbin Yao | Director | Jul 5, 2023 | |||
| Timothy Bertram | Director | Jul 5, 2023 | |||
| John Trainer | Chief Financial Officer | Apr 4, 2023 | |||
| Alan S. Roemer | Director | -$16K | Nov 21, 2023 | ||
| Albert N. Marchio II | Interim Chief Financial Officer Exhibit 24.1 - Power of Attorney | Apr 5, 2024 | |||
| Kristi Jones | President and CEO, Director | Jun 11, 2024 | |||
| Mathias Oelke | Chief Science Officer | Apr 4, 2023 | |||
| Robert Douglas Knight | Chief Medical Officer | Apr 5, 2022 | |||
| Leena Gandhi | Director | Jul 5, 2023 | |||
| Paul D'Angio | Director | Jul 5, 2023 | |||
| Grant Verstandig | Director | Jul 5, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|